Cargando…
Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews
PURPOSE: Metastatic castration-resistant prostate cancer (mCRPC) is a lethal disease that imposes a major burden on patients and healthcare systems. Three structured literature reviews (treatment guidelines, treatment landscape, and human/clinical/patient burden) and one systematic literature review...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565658/ https://www.ncbi.nlm.nih.gov/pubmed/37829336 http://dx.doi.org/10.3389/fonc.2023.1240864 |
_version_ | 1785118743015194624 |
---|---|
author | Leaning, Darren Kaur, Gagandeep Morgans, Alicia K. Ghouse, Ray Mirante, Osvaldo Chowdhury, Simon |
author_facet | Leaning, Darren Kaur, Gagandeep Morgans, Alicia K. Ghouse, Ray Mirante, Osvaldo Chowdhury, Simon |
author_sort | Leaning, Darren |
collection | PubMed |
description | PURPOSE: Metastatic castration-resistant prostate cancer (mCRPC) is a lethal disease that imposes a major burden on patients and healthcare systems. Three structured literature reviews (treatment guidelines, treatment landscape, and human/clinical/patient burden) and one systematic literature review (economic burden) were conducted to better understand the disease burden and unmet needs for patients with late-stage mCRPC, for whom optimal treatment options are unclear. METHODS: Embase(®), MEDLINE(®), MEDLINE(®) In-Process, the CENTRAL database (structured and systematic reviews), and the Centre for Reviews and Dissemination database (systematic review only) were searched for English-language records from 2009 to 2021 to identify mCRPC treatment guidelines and studies related to the treatment landscape and the humanistic/economic burden of mCRPC in adult men (aged ≥18 years) of any ethnicity. RESULTS: In total, six records were included for the treatment patterns review, 14 records for humanistic burden, nine records for economic burden, three records (two studies) for efficacy, and eight records for safety. Real-world treatment patterns were broadly aligned with treatment guidelines and provided no optimal treatment sequencing beyond second line other than palliative care. Current post-docetaxel treatments in mCRPC are associated with adverse events that cause relatively high rates of treatment discontinuation or disruption. The humanistic and economic burdens associated with mCRPC are high. CONCLUSION: The findings highlight a lack of treatment options with novel mechanisms of action and more tolerable safety profiles that satisfy a risk-to-benefit ratio aligned with patient needs and preferences for patients with late-stage mCRPC. Treatment approaches that improve survival and health-related quality of life are needed, ideally while simultaneously reducing costs and healthcare resource utilization. |
format | Online Article Text |
id | pubmed-10565658 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-105656582023-10-12 Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews Leaning, Darren Kaur, Gagandeep Morgans, Alicia K. Ghouse, Ray Mirante, Osvaldo Chowdhury, Simon Front Oncol Oncology PURPOSE: Metastatic castration-resistant prostate cancer (mCRPC) is a lethal disease that imposes a major burden on patients and healthcare systems. Three structured literature reviews (treatment guidelines, treatment landscape, and human/clinical/patient burden) and one systematic literature review (economic burden) were conducted to better understand the disease burden and unmet needs for patients with late-stage mCRPC, for whom optimal treatment options are unclear. METHODS: Embase(®), MEDLINE(®), MEDLINE(®) In-Process, the CENTRAL database (structured and systematic reviews), and the Centre for Reviews and Dissemination database (systematic review only) were searched for English-language records from 2009 to 2021 to identify mCRPC treatment guidelines and studies related to the treatment landscape and the humanistic/economic burden of mCRPC in adult men (aged ≥18 years) of any ethnicity. RESULTS: In total, six records were included for the treatment patterns review, 14 records for humanistic burden, nine records for economic burden, three records (two studies) for efficacy, and eight records for safety. Real-world treatment patterns were broadly aligned with treatment guidelines and provided no optimal treatment sequencing beyond second line other than palliative care. Current post-docetaxel treatments in mCRPC are associated with adverse events that cause relatively high rates of treatment discontinuation or disruption. The humanistic and economic burdens associated with mCRPC are high. CONCLUSION: The findings highlight a lack of treatment options with novel mechanisms of action and more tolerable safety profiles that satisfy a risk-to-benefit ratio aligned with patient needs and preferences for patients with late-stage mCRPC. Treatment approaches that improve survival and health-related quality of life are needed, ideally while simultaneously reducing costs and healthcare resource utilization. Frontiers Media S.A. 2023-09-27 /pmc/articles/PMC10565658/ /pubmed/37829336 http://dx.doi.org/10.3389/fonc.2023.1240864 Text en Copyright © 2023 Leaning, Kaur, Morgans, Ghouse, Mirante and Chowdhury https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Leaning, Darren Kaur, Gagandeep Morgans, Alicia K. Ghouse, Ray Mirante, Osvaldo Chowdhury, Simon Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
title | Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
title_full | Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
title_fullStr | Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
title_full_unstemmed | Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
title_short | Treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
title_sort | treatment landscape and burden of disease in metastatic castration-resistant prostate cancer: systematic and structured literature reviews |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10565658/ https://www.ncbi.nlm.nih.gov/pubmed/37829336 http://dx.doi.org/10.3389/fonc.2023.1240864 |
work_keys_str_mv | AT leaningdarren treatmentlandscapeandburdenofdiseaseinmetastaticcastrationresistantprostatecancersystematicandstructuredliteraturereviews AT kaurgagandeep treatmentlandscapeandburdenofdiseaseinmetastaticcastrationresistantprostatecancersystematicandstructuredliteraturereviews AT morgansaliciak treatmentlandscapeandburdenofdiseaseinmetastaticcastrationresistantprostatecancersystematicandstructuredliteraturereviews AT ghouseray treatmentlandscapeandburdenofdiseaseinmetastaticcastrationresistantprostatecancersystematicandstructuredliteraturereviews AT miranteosvaldo treatmentlandscapeandburdenofdiseaseinmetastaticcastrationresistantprostatecancersystematicandstructuredliteraturereviews AT chowdhurysimon treatmentlandscapeandburdenofdiseaseinmetastaticcastrationresistantprostatecancersystematicandstructuredliteraturereviews |